Eli Lilly's (LLY, Financial) stock experienced a notable movement, rising 1.71% to a price of 913.72.ThissurgewasdrivenbytheCongressionalBudgetOffice(CBO)reportonthepotentialimpactifMedicareweretocoveranti−obesitymedications,includingEliLilly′sweightlossdrug,Zepbound.TheCBOestimatesthisMedicarecoveragecouldincreasefederalspendingby35 billion from 2026 to 2034, underscoring the significant sales potential for GLP-1 drugs in the weight loss market. Investors have resp ...